Illumina, Genospectra, Enzo Biochem | GenomeWeb

Illumina last week launched two SNP-based assay panels designed to study genetic variation and function in the major histocompatibility complex region of the human genome, the company said.

The MHC Exon-Centric Panel consists of 1,228 SNPs in or within 10 kb of protein-coding regions, while the MHC Mapping Panel includes 1,293 SNPs evenly distributed across the entire region. The MHC is believed to contribute to many common autoimmune and inflammatory disorders including multiple sclerosis, type-1 diabetes and rheumatoid arthritis, Illumina said.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.